Proton Pump Inhibitors Use in Patients With Ischemic Stroke on Dual Antiplatelet Therapy at Low Risk of Upper Gastrointestinal Bleeding
In patients with IS receiving dual antiplatelet therapy, PPI use reduced the risk of significant UGIB by 37% on average, even among low-risk patients. However, the use of PPIs in this patient group was limited, highlighting the need for additional prospective studies.
Authors
- Jimin Jeon (ORCID: https://orcid.org/0000-0003-1497-3914)
- Jinkwon Kim (ORCID: https://orcid.org/0000-0003-0156-9736)
- Joonsang Yoo (ORCID: https://orcid.org/0000-0003-1169-6798)
- Seok‐Jae Heo (ORCID: https://orcid.org/0000-0002-8764-7995)
- Minyoul Baik (ORCID: https://orcid.org/0000-0002-6582-0953)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1161/jaha.124.035239
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.21